Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
LDLR- |
RCV000238404 | SCV000295866 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-25 | criteria provided, single submitter | literature only | |
Cardiovascular Research Group, |
RCV000238404 | SCV000599403 | pathogenic | Hypercholesterolemia, familial, 1 | 2016-03-01 | criteria provided, single submitter | curation | |
Brunham Lab, |
RCV000238404 | SCV001432558 | pathogenic | Hypercholesterolemia, familial, 1 | 2019-06-04 | criteria provided, single submitter | research | |
Revvity Omics, |
RCV000238404 | SCV003831288 | likely pathogenic | Hypercholesterolemia, familial, 1 | 2022-11-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003581640 | SCV004297877 | pathogenic | Familial hypercholesterolemia | 2024-06-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys698Alafs*11) in the LDLR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LDLR are known to be pathogenic (PMID: 20809525, 28645073). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with hypercholesterolemia (PMID: 11845603). ClinVar contains an entry for this variant (Variation ID: 252214). For these reasons, this variant has been classified as Pathogenic. |